Levetiracetam Thame

Levetiracetam, the active ingredient in Levetiracetam Thame, is an anticonvulsant presented as an oral tablet for oral administration. It is used to control partial‑onset, generalized tonic‑clonic, and myoclonic seizures in individuals diagnosed with epilepsy.

GNH USA supplies Levetiracetam Thame as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality, regulatory compliance, and reliable global distribution.

Levetiracetam is an anticonvulsant indicated for several seizure disorders.

- Partial-onset seizures: reduces the frequency of focal seizures in patients with epilepsy. - Generalized tonic-clonic seizures: helps prevent convulsive episodes in generalized epilepsy. - Myoclonic seizures: controls rapid, brief muscle jerks associated with myoclonic epilepsy.

Levetiracetam may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness - Somnolence - Fatigue - Headache - Irritability - Nausea

Serious or Rare Side Effects: - Severe allergic reactions such as Stevens‑Johnson syndrome - Mood changes including depression or suicidal thoughts - Severe skin rash - Hematologic abnormalities like thrombocytopenia - Multi‑organ hypersensitivity reactions - Rare hepatic dysfunction

When prescribing Levetiracetam, clinicians should consider several precautionary measures to ensure safe use.

- Renal impairment: adjust dose based on creatinine clearance. - History of psychiatric disorders: monitor mood and behavior closely. - Concomitant CNS depressants: assess additive sedation risk. - Pregnancy: evaluate risk‑benefit as data are limited. - Elderly patients: start at lower dose and titrate cautiously. - Store at ambient temperature: keep in original container, protect from moisture and heat.

Levetiracetam can interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma levels. - Phenobarbital: may decrease levetiracetam exposure. - Phenytoin: may lower levetiracetam concentrations.

Moderate Interactions (Monitor Closely): - Alcohol: may increase central nervous system depression. - Other antiepileptic drugs (e.g., valproate): may require dose adjustment. - Renal excretion inhibitors (e.g., probenecid): may increase levetiracetam levels.